🇺🇸 FDA
Patent

US 12209073

Polymorphs of a dihydroorotate dehydrogenase (DHOD) inhibitor

granted A61PA61P29/00A61P35/00

Quick answer

US patent 12209073 (Polymorphs of a dihydroorotate dehydrogenase (DHOD) inhibitor) held by KIORA PHARMACEUTICALS GmbH expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
KIORA PHARMACEUTICALS GmbH
Grant date
Tue Jan 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P29/00, A61P35/00